Teva got a nice shot in the arm after reports that billionaire investor Warren Buffett took a stake in the company. Source: BioSpace

Janssen got a little love from the FDA on Wednesday. Source: BioSpace

Vertex has declined to comment, but BioCentury received a copy of the letter the company sent to laboratories explaining. Source: BioSpace

Mr. Cross has held the position of President and COO of GTBP since November 16, 2017. Source: BioSpace

Analyst price targets for these two biotechs suggest they could double your money. Here's what you need to know. Source: BioSpace

The Phase 3 program is the first trial in the JAK1 Atopic Dermatitis Efficacy and Safety global development program. Source: BioSpace

A 60-year-old chemist has been charged with stealing 219.79 grams of potassium cyanide, a deadly poison, from a Merck facility in Pennsylvania. Source: BioSpace

The phase 3 IGNITE3 clinical trial enrolled 1,205 patients who were randomized 1:1 to receive IV eravacycline or ertapenem. Source: BioSpace

The stock market has been rocky recently, but overall the biotech market appears to have been comparatively stable. Source: BioSpace

Alzheimer's drug development took another hit. Source: BioSpace